Organigram Holdings Inc. (NASDAQ:OGI – Get Free Report) was the target of a large increase in short interest in the month of February. As of February 28th, there was short interest totalling 5,400,000 shares, an increase of 25.6% from the February 13th total of 4,300,000 shares. Approximately 6.5% of the shares of the company are short sold. Based on an average daily trading volume, of 991,800 shares, the short-interest ratio is presently 5.4 days.
Organigram Stock Performance
NASDAQ OGI opened at $1.07 on Wednesday. The company has a fifty day simple moving average of $1.36 and a 200 day simple moving average of $1.56. The company has a market cap of $135.05 million, a P/E ratio of -2.82 and a beta of 1.01. Organigram has a 1 year low of $0.96 and a 1 year high of $2.91.
Organigram (NASDAQ:OGI – Get Free Report) last issued its quarterly earnings results on Tuesday, February 11th. The company reported ($0.05) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.02). Organigram had a negative net margin of 31.69% and a negative return on equity of 8.59%. Equities research analysts forecast that Organigram will post -0.19 EPS for the current fiscal year.
Institutional Trading of Organigram
Organigram Company Profile
Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.
Read More
- Five stocks we like better than Organigram
- What is the FTSE 100 index?
- Retail Sales Data Signals a Surge: The E-Commerce Stock Picks
- The Basics of Support and Resistance
- Qualcomm’s Low PE Ratio Makes It A Seriously Attractive Stock
- How is Compound Interest Calculated?
- Dollar General Stock Jumps—Will Its Turnaround Plan Work?
Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.